Home » Newsletters » BioWorld Science

BioWorld Science

May 8, 2012

View Archived Issues

Radius Health scientists design novel SARMs

Roche presents new potential products to treat/prevent CMV infection

Biota Holdings presents novel antibacterials

Interferon-free combination therapy shows promise to treat chronic hepatitis C

Encouraging phase I data reported on candidate arthritis immunotherapy

Pretargeted radioimmunotherapy is safe, specific and fast in patients with colorectal tumors

Korean team discovers novel serum biomarker of ovarian carcinoma

Genocea Biosciences presents potential HSV-2 vaccine at ongoing conference

Proteostasis Therapeutics to collaborate with CFFT

Interim data reported from combination study in CF

Sunovion confirms upcoming availability of ciclesonide nasal aerosol

Iluvien gains U.K. marketing authorization

Aeterna Zentaris regains rights to perifosine

Galleon Pharmaceuticals reports phase I GAL-021 study results

FDA clears p53 image analysis algorithm

Alder BioPharmaceuticals launches phase I trial of mAb for migraine

German BfArM issues recommendation on Pliaglis MAA

Santen and Bayer Yakuhin enter copromotion agreement

First-in-human data disclosed on topical RNAi drug for ocular pain

New phase III study of Adcetris begins

Immunomic Therapeutics clear to launch phase I trial of Japanese red cedar allergy vaccine

New candidate drugs for tuberculosis designed at GSK

Investigation at Roche yields novel TWEAK-specific antibodies

Envoy Therapeutics receives second grant from Michael J. Fox Foundation

FDA extends PDUFA date for Marqibo NDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...